DRMAW vs PSX
Dermata Therapeutics Inc. Warrant (DRMAW) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
DRMAW does not have a complete income-statement cache yet.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
DRMAW currently screens at market cap $0. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the DRMAW and PSX stock pages for the full models.
Not investment advice.